[1]蔺雪梅,王 芳,王 静,等.RRE90、ESRS和SPIⅡ评分对缺血性脑卒中复发风险预测价值比较*[J].陕西医学杂志,2019,(5):599-602.
　LIN Xuemei,WANG Fang,WANG Jing,et al.Comparison of predictive value of RRE90, ESRS, and SPIII scores for recurrent risk in ischemic stroke patients[J].,2019,(5):599-602.
点击复制

RRE90、ESRS和SPIⅡ评分对缺血性脑卒中复发风险预测价值比较*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年5期
页码:
599-602
栏目:
临床研究
出版日期:
2019-05-05

文章信息/Info

Title:
Comparison of predictive value of RRE90, ESRS, and SPIII scores for recurrent risk in ischemic stroke patients
文章编号:
DOI: 10.3969/j.issn.10007377.2019.05.016
作者:
蔺雪梅; 王 芳; 王 静; 逯青丽; 曹 欢; 段康丽; 吴松笛
西安市第一医院（西安 710002）
Author(s):
LIN Xuemei;  WANG Fang;  WANG Jing;  et al.
The First Hospital of Xi’an（Xi’an 710002）
关键词:
缺血性脑卒中; 复发; 复发风险评估量表; 卒中风险评估量表; 卒中预测工具Ⅱ; 预测效能
Keywords:
Key words Ischemic stroke; Recurrence; RRE90; ESRS; SPIⅡ; Predictive value
分类号:
R743.3
文献标志码:
A
摘要:
摘 要 目的：比较90 d复发风险评估量表（RRE90）、ESSEN卒中风险评估量表（ESRS）和卒中预测工具Ⅱ（SPIⅡ）量表对缺血性脑卒中患者卒中复发的预测价值。方法：前瞻性连续纳入诊治的急性缺血性脑卒中患者，全面收集患者的临床资料。住院期间对患者进行RRE90、ESRS和SPIⅡ量表评分。患者出院后1月、3月、6月及1年时进行随访，记录卒中复发情况。计算各个随访点三种评分受试者工作曲线下面积（AUC），对比三种量表预测卒中复发的效能。结果：排除基线不全、失访等患者后，研究最终纳入患者471例。1年随访结束时，卒中复发40例，累计复发率为8.75%。对比各随访点RRE90、ESRS和SPIⅡ评分的AUC发现，随访1月、3月时RRE90预测效能优于ESRS和SPIⅡ（P＜0.05），1年时ESRS和SPIⅡ预测效能则优于RRE90（P＜0.05）。ESRS与SPIⅡ预测效能类似（P＞0.05）。结论：应用RRE90、ESRS和SPIⅡ量表均能预测卒中复发。RRE90对卒中短期复发预测效果优于ESRS和SPIⅡ量表，ESRS和SPIⅡ量表对卒中复发预测效能效果相近，且在预测卒中长期复发上二者均优于RRE90。
Abstract:
Abstract Objective: To compare the predictive value of 90day Recurrence Risk Estimator (RRE90), the ESSEN Stroke Risk Score (ESRS) and the Stroke Prognostic Instrument II (SPIII) for recurrent risk in patients with ischemic stroke.Methods: Patients with acute ischemic stroke were prospectively enrolled. The clinical data about the patients were collected. RRE90, ESRS and SPIII scales were assessed during hospitalization. All the patients were followed up at 1 month, 3 months, 6 months, and 1 year after discharge and stroke recurrence was recorded.The area under the curve (AUC) of the three scores at each followup point was calculated and to compare the predictive efficacy of the three scales for stroke recurrence.Results: After exclusion of patients with incomplete baseline data and loss of followup, 471 patients were eventually included in the study. At the end of the 1year followup, there were 40 patients stroke reoccurred and the cumulative stroke recurrent rate was 8.75%. Compared with the AUC of RRE90, ESRS and SPIII scores at each followup point, the predictive value of RRE90 was superior to that of ESRS and SPIII at 1 and 3month followup (P＜0.05), and the predictive value of ESRS and SPI II was better than that of RRE90 at 1year followup (P＜0.05). The predictive value between ESRS and SPIII was similar (P＞0.05).Conclusions: All of RRE90, ESRS and SPIII scales can predict stroke recurrence. RRE90 is superior to the ESRS and SPIII scales in predicting shortterm stroke recurrence. The ESRS and SPIII scales have similar efficacy in predicting stroke recurrence and both are superior to RRE90 in predicting longterm stroke recurrence.

参考文献/References:

[1] 王陇德,刘建民,杨 弋,等.《中国脑卒中防治报告2017》概要[J].中国脑血管病杂志, 2018,15(11):611-617. [2] 李筱婷, 何剑波, 翟洁敏.卒中单元治疗脑卒中患者复发危险因素分析[J].陕西医学杂志, 2013,42(8)：966-968. [3] Park JH,Ovbiagele B.Relationship of functional disability after a recent stroke with recurrent stroke risk[J].Eur J Neurol,2016,23(2):361-367. [4] The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators[J]. Journal of Clinical Epidemiology,1988,41(2):105-114. [5] Hankey GJ. Secondary stroke prevention[J].The Lancet Neurology,2014,13(2):178-194. [6] Arsava EM,Kim GM,OliveiraFilho J,et al.Prediction of early recurrence after acute ischemic stroke[J].JAMA Neurol,2016,73(4):396-401. [7] Pendlebury ST,Rothwell PM.Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke[J].Cerebrovasc Dis,2009,27(Suppl 3):1-11. [8] Callaly E, Ni Chroinin D,Hannon N, et al.Rates, predictors, and outcomes of early and late recurrence after stroke: The north dublin population stroke study[J].Stroke,2016,47(1):244-246. [9] Feng W,Hendry RM,Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients[J].Neurology,2010,74(7):588-593. [10] Meng X,Wang Y,Zhao X,et al.Validation of the essen stroke risk score and the stroke prognosis instrument II in Chinese patients[J].Stroke,2011,42(12):36193620. [11] Wang Z, Li J,Wang C, et al.Gender differences in 1year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry[J]. PloS One, 2013,8(2):e56459. [12] Maier IL,Bauerle M,Kermer P, et al. Risk prediction of very early recurrence, death and progression after acute ischaemic stroke[J].Eur J Neurol,2013,20(4):599604. [13] Elkind MS.Outcomes after stroke：risk of recurrent ischemic stroke and other events[J].The American Journal of Medicine,2009,122(4 Suppl 2):S7S13. [14] Arsava EM,Furie KL,Schwamm LH, et al.Prediction of early stroke risk in transient symptoms with infarction: relevance to the new tissuebased definition[J].Stroke,2011,42(8):21862190. [15] Oza R,Rundell K,Garcellano M.Recurrent ischemic stroke:strategies for prevention[J]. American Family Physician,2017,96(7)：436440. [16] 焉双梅,洪 渊,张 欢,等.ESRS和SPIⅡ评分对急性缺血性脑卒中患者复发风险的评估作用[J].中风与神经疾病杂志,2016,33(11):10021005. [17] Weimar C,Benemann J,Michalski D,et al.Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores[J].Stroke,2010,41(3):487493.

相似文献/References:

[1]孙红艳,王改华.不同手术方式治疗卵巢癌临床效果及对患者生育功能的影响[J].陕西医学杂志,2019,(2):213.
　SUN Hongyan,WANG Gaihua..Clinical effects of different surgical treatments on 125 patients with ovarian  cancer and their influence on reproductive function[J].,2019,(5):213.
[2]于庆伟,秦彦昌,张百平,等.长链非编码RNA AFAP1AS1在神经胶质瘤中表达水平及影响预后的相关因素研究[J].陕西医学杂志,2019,(3):297.
　YU Qingwei,QIN Yanchang,ZHANG Baiping,et al.The expression level of long noncoding RNA AFAP1AS1 in glioma and the study about the related factors of prognosis[J].,2019,(5):297.
[3]王 丽,朱红英△,张群昌.宫腔镜联合曼月乐手术治疗子宫内膜息肉疗效观察[J].陕西医学杂志,2019,(7):920.
[4]高铜拴,于 哲,蔡 丹,等.人工髋关节置换治疗股骨近端骨肿瘤疗效及预后影响因素研究*[J].陕西医学杂志,2019,(12):1634.
　GAO Tongshuan,YU Zhe,CAI Dan,et al.Curative effect of artificial hip replacement in the treatment of proximal femoral bone tumors and influencing factors of the prognosis[J].,2019,(5):1634.
[5]戴 皓,李化静,申 震,等.复发性腮腺恶性肿瘤35例诊治分析[J].陕西医学杂志,2020,49(1):87.
　DAI Hao,LI Huajing,SHEN Zhen,et al.Diagnosis and treatment of 35 cases of recurrent parotid malignant carcinoma[J].,2020,49(5):87.
[6]冀 伟,郭 倩,郑广涛,等.GPER抑制IGF2R表达介导缺血性脑卒中的抗炎作用[J].陕西医学杂志,2023,52(4):369.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.002]
　JI Wei,GUO Qian,ZHENG Guangtao,et al.GPER mediates anti-inflammatory effect of ischemic stroke by inhibiting expression of IGF2R[J].,2023,52(5):369.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.002]

备注/Memo

备注/Memo:
*陕西省科技计划项目(2017SF163) 西安市科技计划重大项目 \[201805104YX12SF38(2)\] 西安市卫生和计划生育委员会科技项目(J201703049)
更新日期/Last Update: 2019-05-07